破坏Cdk5减弱瘤PD-L1表达并促进抗瘤免疫力
R Dixon Dorand1, Joseph Nthale2, Jay T Myers2
1Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA. Division of Pediatric Hematology-Oncology, Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
概括
通过对PD-L1进行上调,使得脑髓母细胞瘤能够逃避免疫监测. 在小鼠中抑制Cdk5引发T细胞介导的瘤排斥,突出显示Cdk5
科学领域:
- 癌症学
- 免疫学
- 分子生物学
背景情况:
- 癌症通过PD-L1表达机制逃避免疫监测,
- 在神经元和癌症中活跃的环素依赖激酶5 (Cdk5) 与瘤免疫逃避有关.
研究的目的:
- 调查Cdk5在骨髓母细胞瘤免疫逃避中的作用.
- 要确定Cdk5是否调节脑髓母细胞瘤中的PD-L1表达.
主要方法:
- 使用大脑细胞瘤 (MB) 的小鼠模型.
- 评估Cdk5中断对MB免疫规避的影响.
- 分析了PD-L1表达及其转录调节剂 (IRF2,IRF2BP2).
主要成果:
- 在MB中,因干扰素-γ (IFN-γ) 诱导的PD-L1上调需要Cdk5.
- 在小鼠MB模型中破坏Cdk5导致了强大的CD4 ((+) T细胞介导的瘤排斥.
- Cdk5的丧失导致了PD- L1转录抑制剂IRF2和IRF2BP2的持续表达.
结论:
- 在脑髓母细胞瘤中,Cdk5在调节免疫检查点方面发挥着关键作用.
- 向Cdk5可能是增强抗瘤免疫力的新方法.
相关概念视频
Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Inhibition of CDK Activity
5.6K
5.6K
Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
M-Cdk Drives Transition Into Mitosis
6.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.7K


